Inflammatory markers boosted asthma attack prediction, potentially allowing intensification of treatment, according to a meta ...

Sanofi's statement highlights that the drug is intended for individuals with high levels of eosinophils, a marker of inflammation that contributes to COPD symptoms. By adding Dupixent to their ...

In the course of the ALS development program, however, dexpramipexole was observed to produce a significant and targeted depletion of eosinophils in the blood of ALS patients 4. Eosinophils are ...